TY - CHAP
T1 - Diagnosis, Therapy and Prevention of Wernicke's Encephalopathy
AU - Galvin, R.
AU - Brathen, G.
AU - Ivashynka, A.
AU - Hillbom, M.
AU - Tanasescu, R.
AU - Leone, M. A.
PY - 2011/9/21
Y1 - 2011/9/21
KW - Clinical features of alcohol-dependent WE-different from non-alcohol-dependent WE
KW - Computed tomography (CT)-not a reliable test for WE
KW - Diagnosis, therapy and prevention-of Wernicke's encephalopathy
KW - Disease, rare, catastrophic in onset-clinically complex and delayed in diagnosis
KW - Erythrocyte transketolase activity assay-thiamine pyrophosphate effect
KW - Prophylactic thiamine therapy-and its place in WE
KW - Revised European Federation of Neurological Societies (EFNS) scientific task force guidance
KW - Thiamine supplementation-into food, preventing development of WE (GPP)
KW - WE diagnosed in life, and how often-frequently undiagnosed during life
KW - Wernicke's encephalopathy (WE)-acute or subacute neurological disorder, thiamine(vitamin B1) deficiency
UR - http://www.scopus.com/inward/record.url?scp=84885541199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885541199&partnerID=8YFLogxK
U2 - 10.1002/9781444346268.ch17
DO - 10.1002/9781444346268.ch17
M3 - Chapter
AN - SCOPUS:84885541199
SN - 9781405185349
VL - 2
SP - 239
EP - 252
BT - European Handbook of Neurological Management
PB - Wiley-Blackwell